Bumetanide
NDC 0641-6285, Bumetanide, injection, from Hikma Pharmaceuticals USA Inc..
- Product NDC
- 0641-6285
- Status
- Listed
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Dosage form
- INJECTION
- Route
- INTRAMUSCULAR, INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA079196
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0641-6285 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BUMETANIDE.25 mg/mL
Pharmacologic classes
Increased Diuresis at Loop of Henle [PE]; Loop Diuretic [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0641-6285-10 | 00641628510 | 10 VIAL in 1 CARTON (0641-6285-10) / 10 mL in 1 VIAL (0641-6285-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/b5a68154-8003-4b80-81e2-e926524fb72cMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=0641-6285
Use it
Look up 0641-6285 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0641-6285 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0641-6285. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.